Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What's next for VI-RADS? Updates and future perspectives from the ACR VI-RADS steering committee.

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same author

Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee.

European urology·2025
Same author

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer.

BJUI compass·2025
Same author

Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.

European urology·2025
Same author

Letter: Updates to Microhematuria: AUA/SUFU Guideline (2025).

The Journal of urology·2025
Same author

VI-RADS quality score: development and proposal of a scoring system by the American College of Radiology VI-RADS Steering Committee.

European radiology·2025

Related Experiment Video

Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Individualized image-based lymph node irradiation for prostate cancer.

Hanneke J M Meijer1, Oscar A Debats, Emile N J Th van Lin

  • 1Department of Radiation Oncology [875], Radboud University Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The Netherlands. h.meijer@rther.umcn.nl

Nature Reviews. Urology
|May 29, 2013
PubMed
Summary

The benefit of whole pelvis radiotherapy (WPRT) versus prostate-only radiotherapy (PORT) for prostate cancer remains debated. Advanced imaging may improve lymph node targeting in WPRT for better patient selection and outcomes.

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Related Experiment Videos

Last Updated: May 11, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Area of Science:

  • Oncology
  • Radiotherapy
  • Medical Imaging

Background:

  • Controversy exists regarding whole pelvis radiotherapy (WPRT) versus prostate-only radiotherapy (PORT) for intermediate and high-risk prostate cancer.
  • Conflicting results from randomized trials and retrospective studies highlight the need for further investigation.
  • Limited data are available on WPRT use in patients with biochemical recurrence post-prostatectomy, leading to varied global practices.

Purpose of the Study:

  • To review the current evidence on WPRT versus PORT for prostate cancer.
  • To explore the role of advanced imaging in improving nodal irradiation strategies.
  • To address the scarcity of data on WPRT for post-prostatectomy biochemical recurrence.

Main Methods:

  • Review of existing randomized trials and retrospective studies comparing WPRT and PORT.
  • Discussion of advanced imaging techniques like PET, SPECT, diffusion-weighted MRI, and MRL for lymph node metastasis detection.
  • Analysis of how these imaging modalities can refine patient selection and target volume definition for radiotherapy.

Main Results:

  • Contradictory findings exist between WPRT and PORT in major studies.
  • Advanced imaging techniques show promise for precise lymph node targeting and patient selection.
  • New imaging methods may facilitate dose escalation to involved lymph nodes, potentially improving treatment efficacy.

Conclusions:

  • The optimal radiotherapy strategy (WPRT vs. PORT) for prostate cancer requires further clarification.
  • Advanced imaging offers significant potential to enhance the precision and effectiveness of nodal irradiation in prostate cancer treatment.
  • Further research is needed to establish clear guidelines for WPRT, especially in recurrent disease settings.